Basilea Pharmaceutica (Switzerland) Market Value
| BSLN Stock | CHF 40.60 1.50 3.56% |
| Symbol | Basilea |
Basilea Pharmaceutica 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Basilea Pharmaceutica's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Basilea Pharmaceutica.
| 10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in Basilea Pharmaceutica on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding Basilea Pharmaceutica AG or generate 0.0% return on investment in Basilea Pharmaceutica over 30 days. Basilea Pharmaceutica is related to or competes with Santhera Pharmaceuticals, Idorsia, Molecular Partners, Evolva Holding, and COSMO Pharmaceuticals. Basilea Pharmaceutica AG, a commercial stage biopharmaceutical company, focuses on the development of products that addr... More
Basilea Pharmaceutica Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Basilea Pharmaceutica's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Basilea Pharmaceutica AG upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 5.5 | |||
| Value At Risk | (1.75) | |||
| Potential Upside | 2.17 |
Basilea Pharmaceutica Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Basilea Pharmaceutica's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Basilea Pharmaceutica's standard deviation. In reality, there are many statistical measures that can use Basilea Pharmaceutica historical prices to predict the future Basilea Pharmaceutica's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (0.29) | |||
| Treynor Ratio | (0.61) |
Basilea Pharmaceutica Backtested Returns
Basilea Pharmaceutica secures Sharpe Ratio (or Efficiency) of -0.15, which signifies that the company had a -0.15% return per unit of risk over the last 3 months. Basilea Pharmaceutica AG exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Basilea Pharmaceutica's Mean Deviation of 1.01, standard deviation of 1.26, and Risk Adjusted Performance of (0.05) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.15, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Basilea Pharmaceutica's returns are expected to increase less than the market. However, during the bear market, the loss of holding Basilea Pharmaceutica is expected to be smaller as well. At this point, Basilea Pharmaceutica has a negative expected return of -0.19%. Please make sure to confirm Basilea Pharmaceutica's value at risk, skewness, and the relationship between the maximum drawdown and potential upside , to decide if Basilea Pharmaceutica performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.17 |
Insignificant reverse predictability
Basilea Pharmaceutica AG has insignificant reverse predictability. Overlapping area represents the amount of predictability between Basilea Pharmaceutica time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Basilea Pharmaceutica price movement. The serial correlation of -0.17 indicates that over 17.0% of current Basilea Pharmaceutica price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.17 | |
| Spearman Rank Test | 0.07 | |
| Residual Average | 0.0 | |
| Price Variance | 0.46 |
Basilea Pharmaceutica lagged returns against current returns
Autocorrelation, which is Basilea Pharmaceutica stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Basilea Pharmaceutica's stock expected returns. We can calculate the autocorrelation of Basilea Pharmaceutica returns to help us make a trade decision. For example, suppose you find that Basilea Pharmaceutica has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Basilea Pharmaceutica regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Basilea Pharmaceutica stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Basilea Pharmaceutica stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Basilea Pharmaceutica stock over time.
Current vs Lagged Prices |
| Timeline |
Basilea Pharmaceutica Lagged Returns
When evaluating Basilea Pharmaceutica's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Basilea Pharmaceutica stock have on its future price. Basilea Pharmaceutica autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Basilea Pharmaceutica autocorrelation shows the relationship between Basilea Pharmaceutica stock current value and its past values and can show if there is a momentum factor associated with investing in Basilea Pharmaceutica AG.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Basilea Stock Analysis
When running Basilea Pharmaceutica's price analysis, check to measure Basilea Pharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Basilea Pharmaceutica is operating at the current time. Most of Basilea Pharmaceutica's value examination focuses on studying past and present price action to predict the probability of Basilea Pharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Basilea Pharmaceutica's price. Additionally, you may evaluate how the addition of Basilea Pharmaceutica to your portfolios can decrease your overall portfolio volatility.